Monotherapy Treatment: Ruxoprubart has demonstrated the ability to meet all primary endpoints as a standalone treatment. This allows for a more direct regulatory path, as the drug does not need to be ...

One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...

Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 SC amivantamab is now authorised across all ...

Treatment with SC vs IV tocilizumab led to higher long-term remission rates in GCA-associated aortitis, though imaging and glucocorticoid-sparing outcomes were similar.

NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...

Greece: Researchers have found in a new study that among patients with sepsis, targeted precision immunotherapy aimed at ...

Since August 2025, Halozyme Therapeutics has been in a holding pattern, posting a small loss of 2.1% while floating around ...

Investing.com -- Johnson & Johnson (NYSE:JNJ) announced Monday that the European Commission has approved subcutaneous Rybrevant (amivantamab) for every-three-week and every-four-week dosing schedules ...

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant. The U.S. Food and Drug Administration ...

The fat that can be seen and pinched is subcutaneous. It is located right under the skin and is usually located around the hips, thighs, arms, and abdomen. Though surplus fat in the body may cause ...

TG Therapeutics reported $594M in 2025 U.S. BRIUMVI sales, a 90% YoY increase, and guides for $825–$850M in 2026. Click here ...

WVU Cancer Institute became the first in the world to treat ultra-rare, aggressive CD19-positive MPAL with subcutaneous blinatumomab in a Phase II trial.